Physician profile
Aimee Simington
NPI 1952875932
$964.46
in general payments reported to CMS, 2019-2025
13 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $142 · 2022: $236 · 2023: $144 · 2024: $243 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.31 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $400.78 | 2021-2025 | Jardiance, Synjardy |
| Novo Nordisk INC | $172.72 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $79.68 | 2021-2022 | |
| Lilly USA, LLC | $73.13 | 2022-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $64.20 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $33.51 | 2024-2025 | Airsupra, Breztri |
| Allergan, INC. | $27.64 | 2022 | |
| Glaxosmithkline, LLC. | $20.78 | 2023 | Trelegy Ellipta |
| Abbott Laboratories | $19.80 | 2023 | Freestyle Libre |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2024 | |
| Astellas Pharma US INC | $17.84 | 2023 | Veozah |
| Genentech USA, INC. | $17.44 | 2021 | |
| Seqirus USA INC | $17.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Simington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.